tiprankstipranks
Trending News
More News >
Corline Biomedical AB (SE:CLBIO)
:CLBIO
Sweden Market

Corline Biomedical AB (CLBIO) Financial Statements

Compare
0 Followers

Corline Biomedical AB Financial Overview

Corline Biomedical AB's market cap is currently kr448.18M. The company's EPS TTM is kr-0.137; its P/E ratio is -17.99; Corline Biomedical AB is scheduled to report earnings on November 18, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 9.78Mkr 25.03Mkr 23.55Mkr 7.06Mkr 3.70M
Gross Profitkr 13.44Mkr 28.38Mkr 22.73Mkr 9.10Mkr 10.32M
Operating Incomekr -23.17Mkr -1.79Mkr 2.33Mkr -6.91Mkr -7.29M
EBITDAkr -23.07Mkr -1.69Mkr 2.38Mkr -6.88Mkr -7.27M
Net Incomekr -23.19Mkr -1.81Mkr 2.33Mkr -6.92Mkr -7.29M
Balance Sheet
Cash & Short-Term Investmentskr 17.67Mkr 17.01Mkr 26.21Mkr 41.63Mkr 8.99M
Total Assetskr 94.76Mkr 100.11Mkr 101.78Mkr 101.66Mkr 58.28M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -17.67Mkr -17.01Mkr -26.21Mkr -41.63Mkr -8.99M
Total Liabilitieskr 7.85Mkr 6.79Mkr 7.19Mkr 9.43Mkr 6.25M
Stockholders' Equitykr 86.91Mkr 93.32Mkr 94.59Mkr 92.23Mkr 52.03M
Cash Flow
Free Cash Flowkr -16.14Mkr -9.73Mkr -15.45Mkr -14.45Mkr -13.87M
Operating Cash Flowkr -8.64Mkr 886.00Kkr -6.45Mkr -4.83Mkr -5.07M
Investing Cash Flowkr -7.50Mkr -10.62Mkr -9.00Mkr -9.56Mkr -8.80M
Financing Cash Flowkr 16.79Mkr 537.00Kkr 26.00Kkr 47.13Mkr 0.00
Currency in SEK

Corline Biomedical AB Earnings and Revenue History

Corline Biomedical AB Debt to Assets

Corline Biomedical AB Cash Flow

Corline Biomedical AB Forecast EPS vs Actual EPS